Stay updated on Pembrolizumab in Recurrent PCNSL Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Recurrent PCNSL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Recurrent PCNSL Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision: v3.5.4 replaces the prior v3.5.3, signaling a small metadata update. This change does not modify any study details, eligibility criteria, or results on the page.
    Difference
    0.1%
    Check dated 2026-05-15T15:39:49.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The page’s displayed revision/version number was updated from v3.5.2 to v3.5.3, reflecting a website release rather than a change to the underlying study information.
    Difference
    0.1%
    Check dated 2026-04-24T06:30:42.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:52:23.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Added revision note: v3.5.0. Removed revision note: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T05:30:54.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    Revision history updated to include v3.4.3 and remove v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T00:47:08.000Z thumbnail image
  9. Check
    107 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed older notices (including the lapse in government funding notice and Revision: v3.4.1), which are cosmetic updates and do not modify the study details or core content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T12:34:30.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Recurrent PCNSL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Recurrent PCNSL Clinical Trial page.